MindRank, a clinical-stage artificial intelligence (AI)-empowered drug discovery company, today announced that the first ...
MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001: Shanghai Saturday, February 28, 2026, 18:00 Hrs [IST] MindRank, a cli ...
The rise of nitazenes, highly addictive opioids, needs advanced detection methods to match. Innovative biosensors may be central in helping to address this public health crisis.
Protective Effects of Vitamin D in Necrotizing Enterocolitis of Preterm Infants: From Basic Research to Clinical Translation. Journal of Biosciences and Medicines, 14, 42-56. doi: ...
Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...
Republican Rep. Anna Paulina Luna wants the SAVE America Act, which would require proof of citizenship and photo identification for voters in federal elections, to… Read More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results